gutsandgrowth

Congratulations!
Outcomes in Pediatric “Potential” Celiac Disease Plus One
Micro-Computed Tomographic Imaging Shows the Blurry Line Between Potential Celiac Disease and Celiac Disease
Icotrokinra for Patients with Ulcerative Colitis (ANTHEM-UC Phase 2 Trial)
Enteral Rifaximin May Reduce Central Line Infections in Children with Short Bowel Syndrome
Real-World Outcomes of Risankizumab in Children With Crohn’s Disease
AFFIRM Study: Subcutaneous Induction-Maintenance Data for Risankizumab

Subscribe Subscribed

gutsandgrowth

Join 995 other subscribers

Have a WordPress.com account? Log in now.
gutsandgrowth
View site in Reader
Manage subscriptions Sign up Log in
Report this content
Collapse this bar